Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-13

Clinical Trial Update: Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing combination therapy (etanercept plus methotrexate) to monotherapy (etanercept or methotrexate) in active rheumatoid arthritis; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Active Rheumatoid Arthritis | Phase 3 | Status: COMPLETED